ANALYSIS OF COMORBIDITY IN PNEUMOCOCCAL INFECTIONS
- Authors: Martynova AV1
-
Affiliations:
- Issue: Vol 6, No 3 (2009)
- Pages: 43-46
- Section: Articles
- URL: https://journals.eco-vector.com/1994-9480/article/view/140233
- ID: 140233
Cite item
Full Text
Abstract
Various forms of pneumococcal infections are the most frequent disease in almost all medical specialties. And one of the most important aspects in forecasting the outcome of pneumococcal infection is the evaluation of comorbidity in infection
process caused by the S.pneumoniae. However, until recently, there has been no single method for evaluation of pneumococcal
infection morbidity in patients with different concomitant diseases. We have applied the method of Charleson ME (1987) which
allowed a description of the data on pneumococcal infections morbidity basing on the count of cumulative risk.
process caused by the S.pneumoniae. However, until recently, there has been no single method for evaluation of pneumococcal
infection morbidity in patients with different concomitant diseases. We have applied the method of Charleson ME (1987) which
allowed a description of the data on pneumococcal infections morbidity basing on the count of cumulative risk.
References
- Козлов М. Я. Острые отиты у детей и их осложнения. - Л.: Медицина, 1986. - 232 с.
- Козлов Р. С., Кречикова О. И., Сивая О. В. и др. // Клин. микробиол. антимикроб. химиотер. - 2002.- № 4 (3). - С. 267-277.
- Козлов Р. С. Пневмококки: прошлое, настоящее и будущее. - Смоленск: Смоленская государственная медицинская академия, 2005. - 128 с.
- Сидоренко С. В. // Антибиотики и химиотерапия. - 1998. - Т. 43, № 7. - С. 3-5.
- Страчунский Л. С., Белоусов Ю. Б., Козлов С. Н. Практическое руководство по антиинфекционной химиотерапии. - М.: Боргес, 2002.- С. 32-39.
- Яковлев С. В. // Антибиотики и химиотерапия. - 1999. - Т. 44. - № 5. - С. 3-5.
- Bartlett J. G., Breiman R. F., Mandell L. A., File Jr T. M. // Clin. Infect. Dis. - 1998. - Vol. 26. - P. 811-838.
- Charleson M. E., Pompei P., Ales K. L., McKenzie C. R. // J. Chron. Dis. - 1987. - Vol. 40. - P. 373-383.
- David Nicolau. // J. Antimicrob. Chemother. - 2002. - Vol. 50. - P. 61-70.
- Mandell L. A., Bartlett J. G., Dowell S. F., et al. //Clin. Inf. Dis. - 2003. - Vol. 37. - P. 1405-33.
- Melander E., Molstad S., Persson K., et al. // Eur. J. Clin. Microbiol. Infect. Dis. - 1998. - Vol. 17. - P. 834-883.
Supplementary files
